Metabolic Engineering of Nonplant Pathways
The potential also exists to engineer seeds to produce oils with fatty acids not
normally found in plants. Currently, few examples exist for the transgenic production
of fatty acids that do not normally occur in plants. However, genes from
sources other than plants have been used to alter the fatty acid composition of
seed oils. Early examples include the use of genes for the yeast and mouse
Δ
9-stearoyl-CoA desaturase and the
Synechocystis Δ
6-linoleic acid desaturase to
produce small amounts of novel fatty acids in plants (Moon
et al., 2000; Reddy and
Thomas, 1996). Δ
6-linoleic acid desaturase genes from the fungi
M. alpina and
P. irregulare have been used to generate seed oils in
Brassica species that contain
>40% GLA (Das
et al., 2000; Hong
et al., 2002). This amount of GLA is comparable
to that obtained by transgenic expression of the borage Δ
6 desaturase in soybean
seeds (Sato
et al., 2004).
Perhaps one of the greatest challenges for metabolic engineering of seed oil
composition will be the transgenic production of high levels of the long-chain
o-3 fatty acids eicosapentaenoic acid (EPA; 20:5Δ
5,8,11,14,17) and DHA
(22:6Δ
4,7,10,13,16,19) (Table 7.3). Though EPA can be found in trace amounts in the
seed oil of certain gymnosperm species, this fatty acid and DHA are typically
absent from seed oils but are major components of many fish and algal oils.
Diets
rich in the ω-3 fatty acids EPA and DHA have been linked to enhanced cardiovascular
fitness (Hu
et al., 2001). In addition, DHA has been shown to improve brain
development when supplemented in infant diets (Uauy
et al., 2003). DHA is
present in mother’s milk, but is absent from infant formula prepared from soybean
and other vegetable oils. Highly refined fish oils that contain EPA and DHA can sell for >$10/pound, whereas conventional soybean oil sells for about $0.20/
pound. The ability to engineer EPA and DHA synthesis in oilseeds therefore offers
a means for significantly increasing not only nutritional quality, but also economic
value of vegetable oils.
A number of pathways might lead to the production of EPA in seeds (Napier,
2007). The most direct biosynthetic route would involve the introduction of three
new enzymes: (1) a Δ
6 desaturase for the conversion of α-linolenic acid to stearidonic
acid, (2) an ELO-type fatty acid elongase to initiate the elongation of stearidonic acid
to ARA (20:4Δ
8,11,14,17), and (3) a Δ
5 desaturase for formation of EPA from ARA
(Fig. 7.4). In addition, most oilseeds contain relatively low amounts of a-linolenic
acid, the initial substrate for this pathway.
As a result, the production of EPA in the
seeds of most crop plants would require not only the introduction of genes for the
three enzymes described above but also enhanced expression of the FAD3 gene
to increase Δ
15-linoleic acid desaturase activity. Reports have demonstrated the
feasibility of assembling the EPA biosynthetic pathway into leaves and seeds of
transgenic plants (Abbadi
et al., 2004; Qi
et al., 2004; Robert
et al., 2005;Wu
et al., 2005).
The production of DHA in oilseeds requires the transgenic expression of genes
for at least two additional enzymes: (1) an ELO elongase to initiate the elongation
of EPA to the C
22 fatty acid docosapentaenoic acid (DPA, 22:5Δ
7,10,13,16,19) and (2) a
Δ
4 ‘‘front-end’’ desaturase to convert DPA to DHA (Fig. 7.4). Genes for Δ
4 desaturases
capable of catalyzing this conversion of DPA have been isolated from
E. gracilis and
Thraustochytrium sp (Meyer
et al., 2003; Qiu
et al., 2001a). Indeed,
production of small amounts of DHA in seeds of
Brassica juncea was recently
achieved by the transgenic expression of genes for an Oncorhynchus mykiss C
18/
C
20-specific ELO and the
Thraustochytrium Δ
4 desaturase along with genes for a
P. irregulare Δ
6 desaturase, a Phytophthora infestans ω3 desaturase,
Thraustochytrium Δ
5 desaturase, acyltransferase and ELO, a
C. officinalis Δ
12 desaturase, and a
P. patens ELO (Wu
et al., 2005).
Although the introduction of this pathway into
seeds of a transgenic plant via the overexpression of nine transgenes is a remarkable
metabolic engineering feat, the low amounts of DHA produced (0.2% of the
total fatty acids) indicate that bottlenecks exist for achieving high levels of this
commercially valuable fatty acid. In this regard, biochemical studies have indicated
that the desaturase and ELO elongases that are required for EPA and DHA
synthesis employ fatty acid substrates esterified to different molecules (Domergue
et al., 2003). The Δ
5 and Δ
6 desaturases from plant, fungal, and algal species use
fatty acids bound to PC as their preferred substrates. In contrast, ELO elongases
accept acyl-CoAs as substrates. The need for fatty acid substrates to move between
pools of PC and acyl-CoAs may limit flux through the engineered EPA and DHA
biosynthetic pathways. Furthermore, polyunsaturated fatty acids (PUFAs) do not
appear to be efficiently channeled into TAG and excluded from accumulating in
membrane lipids of engineered seeds (Abbadi
et al., 2004; Wu
et al., 2005).
Whether
membrane-associated PUFAs will impair the agronomic fitness of seeds has yet to
be addressed.
An alternative mechanism for EPA and DHA biosynthesis has been
demonstrated in the marine bacterium
Shewanella sp. and in the thraustochytrid
Schizochytrium sp. These organisms contain polyketide synthases consisting of multifunctional polypeptides capable of synthesizing EPA and DHA in an
anaerobic manner (Metz
et al., 2001). The possibility of transferring these
pathways to seeds appears daunting considering that EPA synthesis in
Shewanella, for example, results from 5 open-reading frames that code for at least
11 different protein domains. These domains include polypeptides that are
related to 3-ketoacyl synthases, ACP, enoyl reductases, dehydratases, and
acyltransferases.